ORPHA:33408
Bullous lichen planus
Publications
232
60.5th percentile
Trials
0
Interventional, condition-specific
Researchers
807
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Bullous lichen planus is a variant of rare lichen planus characterized by the development of vesico-bullous lesions.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018056
- UMLS:C0023648
- NCIT:C34778
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
232 matched papers (128 in last 10 years) Source
- Phenotype characterisedPresent
5 HPO annotations (e.g. Papule; Pruritus; Abnormal blistering of the skin) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 145 for broader category lichen planus
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
5
Associated phenotypes · MONDO:0018056
- Papule
- Pruritus
- Abnormal blistering of the skin
- Lichenification
- Breast aplasia
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
232
232 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
232 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
128 in the last 10 years · high confidence · 60.5th percentile (publications denominator)
Phrase hits: 232 · MeSH hits: 0
Who's working on it?
807
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Hasan S4 papers · 2024
Department of Oral Medicine and Radiology, Faculty of Dentistry, Jamia Milia Islamia, New Delhi, India.
Papers in Europe PMC - 02Saeed S4 papers · 2024
Amity Institute of Public Health, Amity University, Noida, Uttar Pradesh, India.
Papers in Europe PMC - 03Banerjee I3 papers · 2020
Post Doctoral Trainee (DM- Clinical Pharmacology), Department of Clinical & Experimental Pharmacology, Department of Clinical & Experimental Pharmacology, School of Tropical Medicine , 108 C.R. Avenue, Kolkata, West Bengal, India .
Papers in Europe PMC - 04De D3 papers · 2025
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Papers in Europe PMC - 05Handa S3 papers · 2025
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Papers in Europe PMC - 06Almeida OP2 papers · 2022Papers in Europe PMC
- 07Bowszyc-Dmochowska M2 papers · 2025
Cutaneous Histopathology and Immunopathology Section, Poznan University of Medical Sciences, Poznań, Poland.
Papers in Europe PMC - 08Bröcker EB2 papers · 2010Papers in Europe PMC
- 09Camisa C2 papers · 1986Papers in Europe PMC
- 10Dmochowski M2 papers · 2025
Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, Poznań, Poland.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 145 trials are registered for lichen planus, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
145 interventional trials matched lichen planus, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: lichen planus
145
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06451744·RECRUITING·Cellular and Molecular Biomarkers in Patients With Lichen Planus
Conditions: Lichen Planus·Matched via name phrase
- NCT05973097·RECRUITING·Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT04233749·RECRUITING·The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
Conditions: Lichen Planus Pigmentosus · Erythema Dyschromicum Perstans · Ashy Dermatosis of Ramirez·Matched via name phrase
- NCT05953090·RECRUITING·VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Conditions: Atrophic Vaginitis · Vaginal Atrophy · Genitourinary Syndrome of Menopause · Lichen Sclerosus of Vulva·Matched via name phrase
- NCT07100145·NOT YET RECRUITING·Efficacy of Coconut Gel Compared to Corticosteroid Gel in the Management of Oral Lichen Planus
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT06932848·RECRUITING·The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT06810752·ENROLLING BY INVITATION·Thyme Honey for Management of Oral Lichen Planus
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT07775924·RECRUITING·A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
Conditions: Cutaneous Lichen Planus·Matched via name phrase
- NCT06739551·NOT YET RECRUITING·Systemic Treatment Options for Generalized Lichen Planus
Conditions: Lichen Planus·Matched via name phrase
- NCT07131813·RECRUITING·Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT06981767·RECRUITING·Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT07381595·NOT YET RECRUITING·Role of Subgingival Instrumentation in Oral Lichen Planus
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT06697574·ENROLLING BY INVITATION·Hypnotherapy for Oral Lichen Planus. Patients with Clinically and Histologically Confirmed Oral Lichen Planus Would Be Randomized for Hypnotherapy Vs Psychoeducation About the Pyschoneuroimmune System. Follow Up Would Be Done At 2, 6, 12 Weeks After.
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT07280442·NOT YET RECRUITING·Effectiveness of a Sodium Hyaluronate 0.01% and Sh-Oligopeptide-85 SP Mouthwash for the Treatment of Symptomatic Oral Lichen Planus
Conditions: Oral Lichen Planus·Matched via name phrase
- NCT07492251·NOT YET RECRUITING·Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study.
Conditions: Lichen Penis Planus·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 1 · after dedupe 1 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 1 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (1)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Bullous lichen planus — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Bullous lichen planus"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Bullous lichen planus"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"lichen planus"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T23:36:10.227Z
